SCHEMBL24810447

SCHEMBL24810447

c1ccc(-n2c3ccccc3c3ccc(-c4ccc5c6ccccc6n(-c6ccc(-c7ccc(-c8cccc9c8oc8ccccc89)cc7)cc6)c5c4)cc32)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.48
ATM Q13315 2/20 0.43
KDM4E B2RXH2 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
PRKDC P78527 7/20 0.41
GGPS1 O95749 1/20 0.37
ALDH1A1 P00352 2/20 0.35
PPARG P37231 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
NR2E3 Q9Y5X4 1/20 0.35
NCOR2 Q9Y618 1/20 0.35
HDAC4 P56524 1/20 0.35
PTGES2 Q9H7Z7 1/20 0.35
MEN1 O00255 1/20 0.34
POLB P06746 1/20 0.34
TSHR P16473 1/20 0.34
BRCA1 P38398 1/20 0.34
KMT2A Q03164 1/20 0.34
HSD17B10 Q99714 1/20 0.34
MMP12 P39900 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26788405 1.00 ALOX5 (0.48) ALOX5ATMKDM4EL3MBTL1PRKDC
SCHEMBL17285329 0.99 ALOX5 (0.49) ALOX5ATMKDM4EL3MBTL1PRKDC
SCHEMBL19238730 0.99 ALOX5 (0.49) ALOX5ATMKDM4EL3MBTL1PRKDC
SCHEMBL24173854 0.98 ALOX5 (0.48) ALOX5ATMKDM4EL3MBTL1PRKDC
SCHEMBL24568806 0.98 ALOX5 (0.48) ALOX5ATMKDM4EL3MBTL1PRKDC
SCHEMBL18505301 0.97 ALOX5 (0.45) ALOX5ATMKDM4EL3MBTL1PRKDC
SCHEMBL18505305 0.97 ALOX5 (0.45) ALOX5ATMKDM4EL3MBTL1PRKDC
SCHEMBL19271579 0.97 ALOX5 (0.45) ALOX5ATMKDM4EL3MBTL1PRKDC
SCHEMBL16804075 0.97 ALOX5 (0.45) ALOX5ATMKDM4EL3MBTL1PRKDC
SCHEMBL12158871 0.96 ALOX5 (0.51) ALOX5ATMKDM4EL3MBTL1PRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230371373-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ldemitsu Kosan Co.,Ltd. (JP) 2023-11-16 US disclosed
US-20230371373-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ldemitsu Kosan Co.,Ltd. (JP) 2023-11-16 US disclosed
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 ALOX5 3499/4885ATM 3436/4885KDM4E 3416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.